IPHA - Innate Pharma and Merus gets FDA Breakthrough Therapy Designation for their respective treatments
2025-02-18 13:49:24 ET
More on Innate Pharma, Merus, etc.
- Time To Upgrade Merus N.V. To A 'Buy' After The Recent Selloff
- Innate Pharma: Looking Like A Company We'll Regret Ignoring
- Merus and Biohaven to co-develop three novel bispecific ADC programs
- Innate Pharma presents lacutamab improved health-related quality of life data at ASH 2024
- Seeking Alpha’s Quant Rating on Innate Pharma